Baseline hemoglobin and neutrophil-to-lymphocyte ratio as prognostic biomarkers in patients with metastatic triple negative breast cancer treated with sacituzumab govitecan in second line and beyond: a real-world analysis.

Breast Cancer Res Treat · 2025 · PMC12583401 · PMID 41014400

Europe PMC DOI

hedged sentence

0.3900

closest p · 7.8× alpha

0.3900

boldest claim

The sentences

did not reach statistical significancep = 0.39not close (p > 0.1)

Similarly, a weak positive correlation was observed between NLR and Ki-67 ( r = 0.1), but this too did not reach statistical significance ( p = 0.39).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.